Biotech China 2014

View Profile


Grant Support

Start year End year Title Source Position
1. 2007 Present A phase II study of neoadjuvant Lapatinib plus chemotherapy (Sequential FEC75 and Paclitaxel) in women with inflammatory breast cancer whose tumors overexpress PI - Massimo Cristofanilli Co-Principal Investigator
2. 2003 Present A pilot study of biodistribution, pharmacokinetics and radiation dosimetry of intratumoral injection of radioactive gallium iron macroaggregates (GIMA) into human breast cancer Department of Defense Breast Cancer Research Program Collaborator
3. 2000 Present Cyclin E as a prognostic factor for breast cancer Department of Defense Breast Cancer Research Program Co-Principal Investigator
4. 2000 Present Correlation of Breast Cancer Biomarkers With Clinical Outcome LAB00-219 Principal Investigator
5. 1999 Present Phase III Trial of Tamoxifen Alone vs. Tamoxifen Plus RT for Good-risk Ductal Carninoma-In-Situ (DCIS) of the Female Breast PI - Eric Strom Collaborator
6. 1998 Present Radiosensitivity And Biological Aging Of Normal Skin Fibroblast as Predictors of Normal Tissue Treatment Response PO1-6294 Principal Investigator
7. 1978 Present Cancer Center Support Grant PI - Mendelsohn J Program Member
8. 2009 Breast Brachytherapy:A Population-Based Study of Treatment Utilization, Quality, and Cost Department of Defense Co-Principal Investigator
9. 2007 2009 In vitro and in vivo radiosensitivity studies-strategy for preclinical testing of context-specific agents combined with radiation Merck & Company Principal Investigator
10. 2007 2009 Creation of the rare and aggressive breast cancer research program PI - M. Cristofanilli Co-Principal Investigator
11. 2006 2009 Characterization of radiation resistance stem cell phenotypes in human breast cancer. PI - Wendy Woodward Mentor
12. 2005 2009 Full member application PI - Scott Lippman Advisor
13. 2008 UTMDACC SPORE in Breast Cancer PI - GN Hortobagyi Mentor for career development
14. 2008 Multidsciplinary Breast Cancer Research Fellowship, Susan G. Komen Breast Cancer Foundation PI - GN Hortobagyi Program Leader
15. 2006 2008 Weight Gain Prevention for Breast Cancer Survivors Lance Armstrong Foundation, PI - Karen Basen-Engquist Collaborator
16. 2005 2008 Burden of breast cancer related lymphedema on working American families American Cancer Society (ACS), PI - Shih Co-Investigator
17. 2001 2008 Molecular Profiles Associated With Neoadjuvant Paclitaxel And FEC Chemotherapy +/- Trastuzumab For HER-2 Overexpressing Operable Breast Cancer PI - Francisco Esteva Collaborator
18. 2007 Estrogen receptor/MAPK cross-talk as a mechanism of radioresistance of breast cancer Department of Defense (DOD), PI - Anupama Munshi Co-Investigator
19. 2007 Patterns of Care and Disparities in the Treatment of Early Breast Cancer Department of Defense (DOD), PI - Grace L. Smith Primary Mentor
20. 2003 2007 Radiation dosimetry of intratumoral injection US Army Medical Research & Materiel Command, PI - Wong Co-Investigator
21. 2003 2006 Investigation of Alpha6Beta4 Integrin as a Prognostic Marker in Breast Cancer Susan G. Komen Breast Cancer Foundation Collaborator
22. 1999 2006 Phase III Trial Of Tamoxifen Alone Vs. Tamoxifen Plus RT For Good-Risk Duct Carcinoma-In-Situ (DCIS) Of The Female Breast RTOG 98-04 Collaborator
23. 2003 2005 Assessing delayed effects of radiation therapy to the carotid artery after treatment for breast cancer The University of Texas M. D. Anderson Cancer Center Principal Investigator
24. 2003 2005 Investigation of Alpha6Beta4 Integrin as a Prognostic Marker in Breast Cancer Susan G. Komen Breast Cancer Foundation, PI - Gilcrease Collaborator
25. 2001 2005 Phase II, Single Arm, Single Institution Clinical Trial Of Docetaxel And Doxorubicin in Combination With Local Administration Of INGN201(Ad5CMV-p53) in Locally Advanced Breast Cancer PI - Massimo Cristofanilli Collaborator
26. 2001 2005 , a powerful predictor of survival in breast cancer - a prospective study US Army Medical Research & Materiel Command, PI - Keyomarsi Co-Investigator
27. 2000 2005 Collection Of Prechemotherapy Core Biopsy From Invasive Breast Cancer to Identify Molecular Predictors of Response To Therapy With Paclitaxel PI - Lajos Pusztai Collaborator
28. 2002 2004 Radiation-Induced Carotid Artery Injury After Radiation Treatment for Breast Cancer: Implications for Prevention of Cerebrovascular Events The University of Texas M. D. Anderson Cancer Center Principal Investigator
29. 2000 2003 Coronary Artery Dosimetry With Left Breast Radiation LAB00-142 Principal Investigator
30. 1998 2002 The value of DNA Damage Susceptibility Assays in Breast Cancer R098-003 Principal Investigator
31. 1999 2001 Randomized Trial Of Post-Mastectomy Radiotherapy In Stage II Breast Cancer In Women With One to Three Positive Axillary Nodes RTOG 99-15, PI - Eric Strom Collaborator
32. 1998 2000 Apoptosis as an Early Predictor of Neoadjuvant Chemotherapy Success in Breast Cancer Physician Referral Service Grant Principal Investigator


4th Annual Pharma R&D Asia Congress
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.